🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to evaluate the efficacy of LXH254 com...
Status
Active Not Recruiting
Location
The Angeles Clinic and Research Institute
Start Date
2020-10-30
Trial ID
NCT04417621
Treatments Being Tested
A Phase I Study of LXH254 in Patients With Advanced Solid Tumors That Harbo...
Status
Terminated
Location
Massachusetts General Hospital MGH Cancer Center
Start Date
2016-01-18
Trial ID
NCT02607813
To evaluate the efficacy of naporafenib administered with trametinib in pat...
Status
Active Not Recruiting
Location
University of California, San Francisco
Start Date
2023-08-17
Trial ID
NCT05907304
Treatments Being Tested
The study purpose is to evaluate the safety, tolerability, and preliminary ...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2018-01-29
Trial ID
NCT03333343
Treatments Being Tested
Stage 1: To select the optimal dose of naporafenib + trametinib to be studi...
Status
Active Not Recruiting
Location
Mayo Clinic - Arizona
Start Date
2024-04-29
Trial ID
NCT06346067
Treatments Being Tested
To characterize safety and tolerability and identify a recommended dose and...
Status
Terminated
Location
University of California San Diego .
Start Date
2017-02-24
Trial ID
NCT02974725
Treatments Being Tested
A phase Ib, open-label platform study of select drug combinations chosen in...
Status
Terminated
Location
University of California LA Santa Monica Location
Start Date
2020-07-22
Trial ID
NCT04294160
Treatments Being Tested